Newsroom

Home / Newsroom / Phase IIa Results from CAR-T CD20 Immuno-Oncology Clinical Development Program for Advanced B-cell Non-Hodgkin Lymphoma
28Oct

Phase IIa Results from CAR-T CD20 Immuno-Oncology Clinical Development Program for Advanced B-cell Non-Hodgkin Lymphoma

Download Full Article as .PDF (Size: 168 kB)

This CBMG article was posted on 28 Oct 2015